Advent International Makes Strategic Growth Investment in Iodine Software

Waystar Acquires Iodine Software

October 1, 2025

Healthcare Services

Waystar Holding Corp. completed the acquisition of Iodine Software, adding Iodine’s clinical dataset and client base of more than 1,000 hospitals and health systems to Waystar’s healthcare payment platform. The deal expands Waystar’s total addressable market by over 15%, strengthens its AI-driven clinical and financial intelligence capabilities, and is expected to be accretive to margins and non-GAAP net income per share in 2027.

Iodine Software Acquires Artifact Health

May 25, 2021

Cloud & SaaS

Iodine Software, a healthcare AI company based in Austin, Texas, has acquired Artifact Health, a Boulder-based physician engagement and mobile query platform. The deal adds Artifact's HIPAA-compliant mobile physician query capabilities to Iodine's Clinical Predictions and Insights platform to expand physician-facing workflows and address mid-revenue-cycle revenue leakage for health systems.

Iodine Software Acquires ChartWise Medical Systems

June 10, 2021

Cloud & SaaS

Iodine Software, a healthcare AI and revenue-cycle solutions provider based in Austin, Texas, has acquired ChartWise Medical Systems, a Wakefield, Rhode Island-based clinical documentation improvement (CDI) SaaS company. The acquisition combines ChartWise’s Best in KLAS CDI workflow with Iodine’s clinical AI capabilities to expand Iodine’s clinical predictions and CDI offerings across hospitals, health systems and outpatient settings.

Advent International to Acquire Significant Stake in Suven Pharmaceuticals

December 26, 2022

Pharmaceuticals

Advent International has entered into a definitive agreement to acquire a significant stake in Suven Pharmaceuticals from the Jasti family and will make an open offer for an additional 26% of public shares. Advent plans to evaluate a merger of its CDMO and API platform company, Cohance Lifesciences, with Suven to create a scaled end-to-end CDMO + merchant API powerhouse serving pharma and specialty chemical markets, subject to board and regulatory approvals.

Advent International Leads Series C Investment in Skyone

December 5, 2025

Cloud & SaaS

Advent International has made a strategic investment in Skyone, a Brazilian cloud, data and AI software company, through Advent's Latin American Private Equity Fund VII as part of Skyone's Series C (terms undisclosed). The funding will support Skyone's international expansion, scale its Skyone Studio and Autosky platforms, and accelerate R&D in AI and cloud capabilities. In connection with the transaction, Inovabra Ventures and select angel investors fully exited while founders and investors Henkan and BeWater remain significant shareholders.

Strattam Capital Makes Majority Growth Investment in Intellect

March 2, 2022

Cloud & SaaS

Strattam Capital made a majority growth investment of over $35 million in Intellect, a Los Angeles–based provider of cloud-based no-code compliance management software, to accelerate product innovation and expand go-to-market efforts. Debt financing for the transaction was provided by TreeLine Capital Partners, and Madison Park Group served as Intellect's exclusive financial advisor.